Marty Glick's Net Worth
$4.98 Million
Who is Marty Glick?
Marty Glick has an estimated net worth of $4.98 Million. This is based on reported shares across multiple companies, which include EYETECH PHARMACEUTICALS INC, and THERAVANCE INC.
SEC CIK
Marty Glick's CIK is 0001277481
Past Insider Trading and Trends
2004 was Marty Glick's most active year for acquiring shares with 2 total transactions. Marty Glick's most active month to acquire stocks was the month of April. 2004 saw Marty Glick paying a total of $32,000.00 for 12,000 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
EYETECH PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.22% | -6.60K |
$36.15 | -$238,590.00 | 533.4K |
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 28
| |||
Form 4
| -5.03% | -28.63K |
$40.90 | -$1,170,762.50 | 540K |
Jul 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 12
| |||
Form 4
| +7.57% | 40K |
—
|
—
| 568.63K |
Feb 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
THERAVANCE INC (INVA) Snapshot price: $18.7201
Executive VP, Finance and CFOMarty Glick owns 267,805 units of Common Stock which is worth $5,013,336.38. In the year 2004 Marty Glick filed a total of 2 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +0.75% | 2K |
$16.00 | $32,000.00 | 267.81K |
Oct 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||